Screening of antimicrobial activity of diarylamines in the 2,3,5-trimethylbenzo[b]thiophene series : a structure-activity evaluation study by Ferreira, Isabel C. F. R. et al.
 1
Screening of antimicrobial activity of diarylamines in the 2,3,5-trimethylbenzo[b]thiophene 
series: a structure-activity evaluation study 
Isabel C.F.R. Ferreira,* Ricardo C. Calhelha, Letícia M. Estevinho and Maria-João R.P. Queiroz  
 
In vitro antimicrobial data against Gram positive, Gram negative bacteria and Candida albicans are 
presented.  
N
R2
R1 = H, F
R2 = H, F, OMe
R3  = H, OMe
R1
R3
H
S
 2
Screening of antimicrobial activity of diarylamines in the 2,3,5-trimethylbenzo[b]thiophene 
series: a structure-activity evaluation study 
 
Isabel C.F.R. Ferreira,1* Ricardo C. Calhelha,1 Letícia M. Estevinho1 and  
Maria-João R.P. Queiroz2 
1Escola Superior Agrária, Instituto Politécnico de Bragança, Campus de Sta. Apolónia, Apartado 1172, 5301-854 
Bragança, Portugal 
2 Departamento de Química, Campus de Gualtar, Universidade do Minho, 4710-057 Braga, Portugal 
 
________________________________________________________________________________ 
Abstract- Gram positive (Bacillus cereus, Bacillus subtilis), Gram negative (Pseudomonas 
aeruginosa, Escherichia coli) bacteria and Candida albicans as a representative of fungi were used 
for screening the in vitro antimicrobial activity of diarylamines in the 2,3,5-trimethyl 
benzo[b]thiophene series bearing different substituents, synthesised by us using the palladium-
catalyzed C-N coupling methodology. The minimal inhibitory concentration (MIC) and structure-
activity relationships (SARs) were evaluated.  
The enhance prevalence of infectious diseases is becoming a world wide problem. Additionally, the 
resistance problem demands that a renewed effort should be made to seek antimicrobial agents 
effective against pathogenic microorganisms resistant to current treatment. Benzo[b]thiophenes are 
important heterocycles as biological active molecules.1-5 Recently we have been interested in the 
palladium-catalyzed aryl amination of benzo[b]thiophenes either in the benzene or in the thiophene 
ring to obtain the corresponding diarylamines and in some cases the tetracyclic aromatic 
compounds resulting from intramolecular cyclizations.6,7. We have been able to establish that under 
the same C-N coupling conditions [Pd(OAc)2 (3mol%), Cs2CO3 (1.4 equiv) and BINAP (4mol%) in 
toluene] it was possible to obtain either primary amines8 or diarylamines7,8 in the benzene ring of 
the benzo[b]thiophene moiety.  
Herein, we describe the structure-activity relationship of a novel series of diarylamines as 
antimicrobial agents. Differently substituted diarylamines derivatives of 2,3,5-
trimethylbenzo[b]thiophene 1 were obtained by C-N palladium-catalyzed cross-couplings in good 
to high yields (50%-quantitative yield) using either the bromo compound 2 or the amino derivative 
3 as coupling components.8 The latter was prepared from compound 2 using also a C-N palladium-
catalyzed cross-coupling with benzophenone imine, followed by acidic hydrolysis in a 60% overall 
yield (Scheme 1).8  
A screening of antibacterial activities using two Gram – (Escherichia coli and Pseudomonas 
aeruginosa) and two Gram + bacteria (Bacillus subtilis and Bacillus cereus) and antifungal using 
Candida albicans was performed for the diarylamines 4-8 and for their benzo[b]thiophene 
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precursors 1-3, to determine the importance of the diarylamine skeleton in this series. The minimal 
inhibitory concentration (MIC in µg/mL) was determined (Table 1) using an adaptation of agar 
streak dilution method based on radial diffusion.9,10 Suspensions of the microorganism were 
prepared to contain approximately 108 cfu/mL and the plates were inoculated. A stock solution of 
the synthesized compound (1000 µg/mL) in DMSO was prepared and graded dilutions of the tested 
compounds were incorporated in a cavity (depth 3mm, diameter 4mm) made in the center of the 
petridish (nutrient agar for antibacterial activity and sabouraud dextrose agar medium for antifungal 
activity). The plates were incubated at 37 ºC (bacteria) or 30 ºC (fungi) for 24h in duplicate. In the 
same conditions different concentrated solutions of Ampiciline, Chloramphenicol (antibacterial) 
and Cyclohexamide (antifungal) in DMSO were used as standards. The MIC was considered to be 
the lowest concentration of the tested compound, which inhibits growth of bacteria or fungi on the 
plate. The diameters of the inhibition zones corresponding to the MICs are presented in Table 1. 
Positive control using only inoculation and negative control using only DMSO in the cavity were 
carried out.  From analysis of Table 1 we can conclude that 2,3,5-trimethylbenzo[b]thiophene 1 is 
not effective against none of the microorganisms tested. Insertion of a bromine atom in the 6-
position (compound 2) shows activity only for Gram + bacteria but with high MICs. The 
substitution of the halogen atom by an amino group (compound 3) lowers the MIC for B. cereus 
and turns it active against C. albicans but still with high MICs.  Diarylamine 4, without substituents 
in the phenyl ring, shows activity either against Gram –  or Gram + bacteria (MIC 200 µg/mL). The 
introduction of a OMe group in the para position (compound 5) lowers the MIC to 100 µg/mL for 
B. cereus and to 50 µg/mL for B. subtilis but increases it  to 1000 µg/mL for Gram – bacteria. The 
introduction of an additional OMe group (compound 6) makes the compound inactive against E. 
coli. Compounds with a F atom in the phenyl ring (7 and 8) show selectivity against Gram + 
bacteria. The presence of the F atom in the ortho position (8) instead of in the para position (7) 
lowers the MIC for B. subtilis from 200 to 50 µg/mL. Although the MICs were higher than the 
values obtained for ampiciline it is the first time that this type of compounds was submitted to anti-
bacterial studies. Diarylamines 5 and 6 were also submitted to anti-fungi preliminary studies using 
Candida albicans and the MIC obtained for compound 5 is comparable to the obtained for 
cyclohexamide (anti-fungal). 
In conclusion, a new diarylamine series as antimicrobial agents based on the 2,3,5-
trimethylbenzo[b]thiophene moiety has been developed. The diarylamine skeleton and the  different 
substituents (H, 1 OMe, 2 OMe or F) proved to be important for activity, changing selectivities and 
MICs, when compared with the functionalized (Br and NH2) benzo[b]thiophene precursors. 
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Table 1. Antimicrobial activity of  the synthesized compounds. 
Compounds Microorganism MIC   (Zone of inhibition) µg/mL            (mm) 
1 
B. cereus (CECT 148) 
B. subtilis (CECT 498) 
E. coli (CECT 101) 
P. aeruginosa (CECT 108) 
C. albicans (CECT 1394) 
- 
- 
- 
- 
- 
2 
B. cereus 
B. subtilis 
E. coli 
P. aeruginosa 
C. albicans 
1000 (12) 
500 (18) 
- 
- 
- 
3 
B. cereus 
B. subtilis 
E. coli 
P. aeruginosa 
C. albicans 
500 (10) 
500 (17) 
- 
- 
1000 (13) 
4 
B. cereus 
B. subtilis 
E. coli 
P. aeruginosa 
200 (18) 
200 (8) 
200 (4) 
200 (16) 
5 
B. cereus 
B. subtilis 
E. coli 
P. aeruginosa 
C. albicans 
100 (4) 
50 (19) 
1000 (4) 
1000 (8) 
12.5 (6) 
6 
B. cereus 
B. subtilis 
E. coli 
P. aeruginosa 
C. albicans  
 200 (24)  
200 (10) 
- 
1000 (10) 
 25  (8) 
7 
B. cereus 
B. subtilis 
E. coli 
P. aeruginosa 
 200 (12) 
 200 (10) 
- 
- 
8 
B. cereus 
B. subtilis 
E. coli 
P. aeruginosa 
200 (9) 
50 (8) 
- 
- 
Ampicillin 
B. cereus 
B. subtilis 
E. coli 
P. aeruginosa 
3.13 (13) 
12.5 (10) 
6.25 (15) 
6.25 (12) 
Choramphenicol B. cereus 3.13 (8) 
Cyclohexamide C. albicans 12.5 (5) 
CECT-Spanish type culture collection of Valencia University 
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Scheme 1. Synthesis of diarylamines and their precursors in the 2,3,5-trimethylbenzo[b]thiophene series.8   
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